BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12381910)

  • 1. Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression.
    Volkmann M; Sinn HP; Gaugel D; Frey M; Hajjar Y; Ludwig J; Hänsel S; Bastert G; Wallwiener D; Fiehn W; Zentgraf H; Huober J
    Oncology; 2002; 63(3):297-305. PubMed ID: 12381910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
    Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
    Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.
    Kulić A; Sirotković-Skerlev M; Jelisavac-Cosić S; Herceg D; Kovac Z; Vrbanec D
    Med Oncol; 2010 Sep; 27(3):887-93. PubMed ID: 19763913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of p53 autoantibodies in the serum of patients with breast cancer.
    Willsher PC; Pinder SE; Robertson L; Nicholson RI; Ellis IO; Bell JA; Blamey RW; Green JA; Robertson JF
    Anticancer Res; 1996; 16(2):927-30. PubMed ID: 8687153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast.
    Regele S; Kohlberger P; Vogl FD; Böhm W; Kreienberg R; Runnebaum IB
    Br J Cancer; 1999 Oct; 81(4):702-4. PubMed ID: 10574259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
    Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F
    Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum p53 autoantibodies and characteristics of human breast cancer.
    Mudenda B; Green JA; Green B; Jenkins JR; Robertson L; Tarunina M; Leinster SJ
    Br J Cancer; 1994 Jun; 69(6):1115-9. PubMed ID: 8198980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
    Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
    Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
    Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.
    Balogh GA; Mailo DA; Corte MM; Roncoroni P; Nardi H; Vincent E; Martinez D; Cafasso ME; Frizza A; Ponce G; Vincent E; Barutta E; Lizarraga P; Lizarraga G; Monti C; Paolillo E; Vincent R; Quatroquio R; Grimi C; Maturi H; Aimale M; Spinsanti C; Montero H; Santiago J; Shulman L; Rivadulla M; Machiavelli M; Salum G; Cuevas MA; Picolini J; Gentili A; Gentili R; Mordoh J
    Int J Oncol; 2006 Apr; 28(4):995-1002. PubMed ID: 16525651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells.
    Vogl FD; Stickeler E; Weyermann M; Köhler T; Grill HJ; Negri G; Kreienberg R; Runnebaum IB
    Oncology; 1999 Nov; 57(4):324-9. PubMed ID: 10575320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
    Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
    Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum p53 antibodies in correlation to other biological parameters of breast cancer.
    Sangrajrang S; Arpornwirat W; Cheirsilpa A; Thisuphakorn P; Kalalak A; Sornprom A; Soussi T
    Cancer Detect Prev; 2003; 27(3):182-6. PubMed ID: 12787724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
    Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
    Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
    Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
    Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
    Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
    Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.
    Neri M; Betta P; Marroni P; Filiberti R; Cafferata M; Mereu C; Ivaldi G; Montanaro F; Puntoni R; Paganuzzi M
    Lung Cancer; 2003 Feb; 39(2):165-72. PubMed ID: 12581569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.